- Home
- SERA vs BCIC Comparison
SERA vs BCIC Comparison
Compare SERA & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SERA | BCIC |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 86.6M |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SERA | BCIC |
|---|---|---|
| Price | $2.10 | $6.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $5.50 | ★ $9.83 |
| AVG Volume (30 Days) | 16.1K | ★ 29.2K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 16.11% |
| EPS Growth | 32.32 | ★ 262.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $177.78 | N/A |
| Revenue Next Year | $755.56 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.56 | $6.70 |
| 52 Week High | $3.95 | $13.50 |
Technical Indicators
Market Signals| Indicator | SERA | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 42.19 |
| Support Level | $1.96 | $6.71 |
| Resistance Level | $2.21 | $7.84 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 47.14 | 48.13 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.